Latest Advances in Next-Generation Sequencing Market by Technology and Growth at CAGR of +21.73% by 2023: Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc.,
The growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. However, factors such as accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. The rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.
View full press release